Prof. Shmuel Banai, MD, Medical Director
Elazer R. Edelman, Ph.D.
Timothy D. Henry, MD
Martin B. Leon, MD
Robert Tahara, MD
Prof. Shmuel Banai, MD, Medical Director
Professor Banai was Medical Director of Neovasc Medical Ltd., a Neovasc Inc. predecessor company. He currently serves as Associate Professor of Medicine and Cardiology at the Tel Aviv University Sackler School of Medicine, as well as Director of Interventional Cardiology of the Division of Cardiology at the Tel Aviv Souraski Medical Center, and as Chief Medial Officer of Innovea Medical Ltd. He is one of Israel’s leading interventional cardiologists and a productive researcher. He is Associate Professor of Medicine and Cardiology at the Hebrew University, Jerusalem and Head of the Interventional Cardiology Department of the Tel-Aviv Sourasky Medical. Over the past 25 years he has held several senior positions including: Director of the Heart Institute at Hadassah Medical Center, Jerusalem Senior Cardiologist at Bikur Cholim Hospital, Jerusalem and Visiting Associate at the National Institute of Health, National Heart, Lung and Blood Institute at Bethesda, Maryland. Prof Banai is licensed to practice both in Israel and the United States and has received several prizes both for his teaching and research. He holds three patents, has delivered lectures throughout the world and has authored more than 70 peer reviewed articles
Elazer R. Edelman, Ph.D.
Elazer R. Edelman received Bachelor’s and Master’s degrees in Electrical Engineering from the Massachusetts Institute of Technology, an M.D. degree with distinction from Harvard Medical School, and then his Ph.D. in Medical Engineering and Medical Physics from the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology. Dr. Edelman’s research interests combine his scientific and medical training. He uses elements of continuum mechanics, digital signal processing and polymeric controlled release technology to examine the cellular and molecular mechanisms that produce accelerated atherosclerosis and transform stable coronary artery disease to unstable coronary syndromes. His most recent publications have focused on how tissue engineered cells might be used for the local delivery of growth factors and growth inhibitors in the study of the mechanisms behind, and potential treatments for: arterial restenosis following balloon angioplasty, vascular bypass and endovascular implantation.
Timothy D. Henry, MD
Timothy D. Henry, MD, FACC, is Director of Research at the Minneapolis Heart Institute Foundation and an Interventional Cardiologist at the Minneapolis Heart Institute/Abbott Northwestern Hospital in Minneapolis, Minnesota. He is a Professor of Medicine and Associate Professor of Clinical Research at the University of Minnesota in the School of Medicine. His research interests include acute coronary syndromes, interventional cardiology, and novel therapies for patients who are not candidates for standard revascularization techniques including stem cell and gene therapy, EECP, and spinal cord stimulation. Dr. Henry has numerous original reports, book chapters, abstracts and invited lectures on these subjects. He is a fellow at the American College of Cardiology and the Society for Coronary Angiography and Interventions, and is a member of Alpha Omega Alpha and the American Heart Association Council on Clinical Cardiology. Dr. Henry has served on the Research Committee for the Minnesota Affiliate of the American Heart Association and the Emergency Care Committee for the American College of Cardiology. He has served on the Steering Committees for a number of large, multicenter trials in acute coronary syndromes and angiogenesis including TIMI-9, IN-TIME, TACTICS, VIVA, AGENT III and several on-going myocardial and peripheral angiogenesis trials. He graduated from medical school at the University of California, San Francisco and received his internal medicine training at the University of Colorado Health Sciences Center and was Chief Medicine Resident. Dr. Henry was a Cardiology Fellow, Chief Cardiology Fellow, and Interventional Cardiology Fellow at the University of Minnesota.
Martin B. Leon, MD
Dr. Leon is currently a Professor of Medicine and an attending physician (interventional cardiology) at NYPH/Columbia University Medical Center in New York. Dr. Leon is also an Associate Director, Centre for Interventional Vascular Therapy. Dr. Leon received his BSc from the State University of New York and his MD from Yale University School of Medicine. Dr. Leon has delivered numerous lectures, conferences, symposia, both national and international. Dr. Leon has co-authored numerous academic and professional papers.
Robert Tahara, MD
Robert Tahara, MD, is the Director, Peripheral Interventions Program at the Bradford Regional Medical Center in Bradford, PA. He attended medical school at State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY and did his residency at University of Nebraska Medical Center, Omaha, NE. Dr. Tahara was the first US physician to use the Metricath Libra catheter during clinical treatment.
